13 December 2017

Specialized ParkinsonNet physiotherapy leads to better care at lower costs. This is the conclusion of large-scale research conducted by the CZ healthcare insurance company and Radboudumc, who studied the medical claims declarations of over four thousand people with Parkinson’s disease for a period of three years. The specialized physiotherapists needed fewer treatment sessions, and the patients sustained fewer complications. The healthcare costs were also significantly lower. The results of this new research will be published in The Lancet Neurology on 13 December.

There is increasing evidence that patients with Parkinson’s disease benefit from allied health interventions, such as physiotherapy or occupational therapy. Parkinson-specific expertise is needed for optimal treatment of people with Parkinson’s disease. Professionals who have been trained as part of the Dutch national ParkinsonNet have this expertise. Previous scientific research showed that the ParkinsonNet approach results in better care at lower costs. However, little was known about the added value of this approach in the long-term, and in day-to-day practice. Therefore, the healthcare insurer CZ initiated an analysis of their medical claims database including 4,381 patients who had data available for a period of 3 years.
 
This results show that patients who had been treated by a specialized physiotherapist sustained significantly fewer complications such as bone fractures, and were also less likely to be admitted to a hospital. There was also a tendency towards a lower mortality rate among those who had received the specialized treatment. The costs of this specialized physiotherapy were also significantly lower. On average, patients claimed almost € 400 less per year for specialized treatment than for regular treatment, and the total annual healthcare costs (including the medical specialist care) were on average € 530 lower per patient, because hospital admissions were avoided. In the Netherlands, this represents an estimated annual cost saving of over € 11 million.
 
Researcher Jan Ypinga from CZ is pleased with the results: “This is the first time that research into this subject has been carried out among such a large, representative patient group, and over several years. We now have insight into the impact of specialized treatment in everyday clinical practice. I’m glad that patients experienced fewer complications, such as a bone fracture after a fall, if they received specialized physiotherapy. This is really good news for people with Parkinson’s disease. And it enables patients and professionals to make a conscious choice for high-quality care.’
 
Professor Bas Bloem from the Radboudumc mainly emphasizes the importance of specialized care for a complex disorder such as Parkinson’s disease: “This analysis of medical claims data sheds new light on the added value of ParkinsonNet in everyday clinical practice. These new findings make it very clear that people with Parkinson’s disease deserve to be treated by an expert with a deep understanding of this complex condition, and who is fully up-to-date on all the latest insights and treatment options.”

Link to publication

Related news items


Grants for science communication at Radboudumc

22 April 2021 Scientists at the Radboudumc have received two KNAW grants, each worth 10,000 euros, for science communication. With the new fund, KNAW underlines importance of making science accessible. read more

UMD Catalist grant for Mohammad Alsady and Federica Conte

24 June 2020 They received this award to explore the potential of hiPS-derived skeletal muscle cells as model to investigate muscular pathophysiologic mechanisms in phosphoglucomutase I deficiency. read more

Bas Bloem elected as new member of the KNAW

30 April 2020 Bas Bloem is an expert in Parkinson's disease. He is also a healthcare innovator, focused on the integration of scientific research and its clinical applications. We congratulate Bas with this election. read more

Towards molecular therapies for Myotonic Dystrophy

1 October 2019 ReCognitION, a new 1.3 M€ European project under the leadership of Peter-Bram ‘t Hoen, Baziel van Engelen and Jeffrey Glennon, was kicked-off in Gent. read more

Useful new test for Parkinson's disease

28 March 2019 Diagnosing Parkinson's is not easy. In particular in the early stages, it can be difficult to distinguish Parkinson's from a group of other disorders that at first sight look identical. read more

Specific sugar is important for muscle function Treat a genetic condition with a pinch of sugar?

2 January 2019 Dirk Lefeber and colleagues have discovered that the sugar sialic acid is important for good muscle and heart function. In a family with muscle problems, they discovered a mistake in a gene that prevents the breakdown of sialic acid. read more